# SRTD Biotech

> German biotech developing selectively expressed RNA therapies designed to activate protein payloads only inside cells carrying specific disease-related RNA markers.

## Why it is interesting

Its €31.5M seed includes a disclosed €7M NRW.BANK equity investment; a 2025 open-access scientific study supplies unusually concrete in-vitro and mouse proof of concept, but does not establish human efficacy or systemic delivery.

## Profile

- **Latest funding:** Seed (completed; announced) — €31.5M (November 9, 2026)
- **Latest known valuation:** Undisclosed (November 9, 2026)
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** seed
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-09
- **Latest funding investors:** Mérieux Equity Partners (Mérieux Innovation 2), NRW.BANK (NRW.Venture EU Tech&Scale), Boehringer Ingelheim Venture Fund, Lilly Ventures, High-Tech Gründerfonds, Anobis Asset

## Key facts

- €31.5M seed announced November 9, 2026; lead Mérieux Equity Partners; co-leads NRW.BANK and Boehringer Ingelheim Venture Fund.
- NRW.BANK disclosed a €7M cheque included within the €31.5M seed, not incremental financing.
- 2025 Nature Communications study shows intracellular RNA-triggered activation in cell models and limited early U87 mouse tumor work; no human results.
- seRNA intracellular cell-specific activation and fusogenic LNP organ delivery are two separate proof requirements.

## Funding history

- Seed (completed; announced) · €31.5M · November 9, 2026
  Source: https://srtd-biotech.com/news/srtd-biotech-raises-a-e31-5-million-seed-round-to-develop-next-generation-precision-mrna-therapeutics/

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 9, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/srtd-biotech